Semaglutide near me: what the evidence says and how to access it safely in the UK

Semaglutide (Wegovy) is licensed in the UK for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure or high cholesterol.
It works on a single gut-hormone pathway (the GLP-1 receptor) reducing appetite, slowing gastric emptying and improving blood-sugar signalling.
The MHRA has warned publicly about counterfeit weight-loss pens sold online; always verify any pharmacy on the GPhC register before purchasing.
NICE recommends semaglutide (TA875) within specialist weight management services; private licensed prescribers can also assess and prescribe it outside the NHS pathway.

If you're searching for semaglutide near you, the straightforward answer is this: in the UK, semaglutide for weight management is a prescription-only medicine called Wegovy, and the safest, legally correct route to it is through a regulated prescriber — not a local shop, not a social-media seller. In clinical trials published in the New England Journal of Medicine (STEP 1), adults using semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of their body weight over 68 weeks. That result, from a rigorously controlled trial, is why demand is high and why it matters enormously that what you access is genuine, clinically supervised and from a pharmacy you can verify.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The evidence behind semaglutide, how access actually works, and what to look for in a legitimate provider

What the trial data tells us about semaglutide's effectiveness

The STEP 1 trial remains the cornerstone of what we know about semaglutide for weight management. Over 68 weeks, adults without diabetes who used the 2.4mg weekly dose alongside a reduced-calorie diet and activity programme lost an average of roughly 15% of body weight — more than three times the loss seen in the placebo group. These were adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition: the same population the medicine is licensed for in the UK.

Since those original results, Novo Nordisk has developed a higher 7.2mg dose. The MHRA approved this as a dedicated single-dose pen in April 2026, with trial data reporting an average weight loss of around 20.7% over 72 weeks, closing the gap with tirzepatide results. If you're comparing options, our Wegovy treatment page covers what both the standard and higher-dose pathways look like in practice.

One misconception worth addressing here: a lot of people assume that a higher dose is automatically better for them personally. Titration exists precisely because tolerance matters as much as efficacy, your prescriber moves you through doses at your own pace, not at the trial's pace. The trial average doesn't predict your individual result, and a clinician's job is to find the dose that works for your body, not to match a statistic.

Treatment starts at 0.25mg and increases in approximately four-weekly steps, assessed by a prescriber at each stage. NHS guidance on semaglutide covers what to expect at each stage of treatment in plain language.

Why 'near me' matters less than you might expect, and what actually does

It's natural to search for something locally when you want it quickly or you want to be able to ask questions face-to-face. For most medicines, that instinct is sound. Semaglutide is different in one important respect: because it is a prescription-only medicine, the prescriber's physical location is largely irrelevant to whether your care is safe and legitimate. What counts is whether the prescribing service is regulated, whether your consultation is reviewed by a real clinician and whether the medicine arrives in genuine, tracked, temperature-controlled packaging.

A GPhC-registered online pharmacy can deliver all of that without you travelling anywhere. At nume, every consultation is personally reviewed the same day by a GPhC-registered Independent Prescriber, a named clinician reads your answers, not software. Medicines are sourced through the licensed UK supply chain, dispensed from our own GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register) and sent via DPD in plain, unbranded packaging.

If proximity genuinely matters to you (perhaps you'd prefer an NHS GP or a local clinic) our page on finding a semaglutide prescriber near you covers both NHS and private in-person routes, what to expect from each, and the questions worth asking any provider before you commit.

NHS access versus private: the honest picture

NICE recommends semaglutide (Wegovy) for weight management under TA875, but only within specialist weight management services, for a maximum of two years, and for adults with a BMI of 35 or above (or 30–34.9 in certain referral circumstances) with at least one weight-related comorbidity. Ethnic-background BMI thresholds are generally 2.5 kg/m² lower. Waiting lists for these specialist services are commonly long in England. The NHS is not the only legitimate route.

Private prescribing is legal, licensed and regulated. The key is that the prescriber must follow the same clinical standards regardless of whether you're paying privately. That means a proper consultation, identity and weight verification, a clinical review of your medical history, and follow-up care. Our Wegovy pricing page sets out what private treatment typically costs in the UK and what a legitimate price should include, consultation, prescription and aftercare, with no hidden extras.

People sometimes ask whether it's cheaper to find semaglutide locally without going through a formal prescribing service. The MHRA has been unambiguous on this: medicines sold without a clinical assessment are a safety risk. Fake pens have been seized across the UK in significant volumes, some containing insulin rather than semaglutide. Report any suspect seller via the MHRA's Yellow Card scheme, which handles both adverse reactions and suspect products.

What a safe semaglutide consultation should include

Whether you access semaglutide through the NHS or a private regulated service, the consultation should do several things. It should assess your BMI and any weight-related conditions. It should check for contraindications, including a history of certain thyroid conditions, pancreatitis or specific gastrointestinal disorders. It should confirm you're not pregnant, breastfeeding or planning to conceive shortly, as semaglutide is not recommended in any of those situations. And it should cover what side effects to expect, particularly the GI effects that are most common in the early weeks of treatment.

If you use oral contraceptives and are starting tirzepatide rather than semaglutide, there's an additional step your prescriber will cover, but for semaglutide specifically, NHS guidance notes no equivalent evidence of reduced pill absorption. Details like this are exactly what a thorough clinical review picks up; they are easy to miss when a process is rushed or automated.

Our semaglutide for weight loss near you page goes into more depth on the eligibility picture, while our general weight loss treatment overview sets out the options currently available in the UK. If you'd like to explore a formulation combining a tan alongside your treatment, our megatan semaglutide page explains how that option works. When you're ready to find out where to access Wegovy, our guide on locating Wegovy near you walks through what to look for in a regulated provider. When you're ready to take the next step, speaking to a prescriber is the right place to start, and that conversation costs nothing at nume.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions